Literature DB >> 19457837

Hoffa's Fat Pad: Evaluation on Unenhanced MR Images as a Measure of Patellofemoral Synovitis in Osteoarthritis.

Frank W Roemer1, Ali Guermazi, Yuqing Zhang, Mei Yang, David J Hunter, Michel D Crema, Klaus Bohndorf.   

Abstract

OBJECTIVE: The purpose of this study was to compare synovitis-like signal changes in Hoffa's fat pad on unenhanced proton density-weighted fat-suppressed sequences with signal alterations in Hoffa's fat pad and peripatellar synovial thickening on T1-weighted fat-suppressed contrast-enhanced sequences in patients with osteoarthritis. SUBJECTS AND METHODS: Fifty patients with osteoarthritis of the knee participated in the study. MRI was performed with triplanar proton density-weighted fat-suppressed sequences and a sagittal T1-weighted fat-suppressed contrast-enhanced sequence. Signal intensity alterations in Hoffa's fat pad were scored semiquantitatively on unenhanced and contrast-enhanced images by two radiologists in consensus. Peripatellar synovial thickness was measured on the T1-weighted fat-suppressed contrast-enhanced images in six locations. Agreement between scoring of signal changes on unenhanced and contrast-enhanced sequences was assessed with kappa statistics. The sensitivity, specificity, and accuracy of scoring of signal-intensity changes on unenhanced images were calculated with T1-weighted contrast-enhanced MRI as the reference standard. In addition, we also examined the relation between signal changes and summed synovial thickness using Spearman's rank correlation coefficient.
RESULTS: Agreement between unenhanced and contrast-enhanced MRI was fair to moderate (weighted kappa = 0.35 and 0.45). The sensitivity of signal intensity changes in Hoffa's fat pad on proton density-weighted fat-suppressed images was high, but specificity was low. Correlations of signal intensity changes in Hoffa's fat pad with synovial thickness were lower for unenhanced scans but all were statistically significant.
CONCLUSION: Signal intensity alterations in Hoffa's fat pad on unenhanced images do not always represent synovitis but are a nonspecific albeit sensitive finding. Semiquantitative scoring of synovitis of the patellofemoral region in osteoarthritis ideally should be performed with T1-weighted contrast-enhanced sequences and should include scoring of synovial thickness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457837     DOI: 10.2214/AJR.08.2038

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  36 in total

Review 1.  An illustrative overview of semi-quantitative MRI scoring of knee osteoarthritis: lessons learned from longitudinal observational studies.

Authors:  F W Roemer; D J Hunter; M D Crema; C K Kwoh; E Ochoa-Albiztegui; A Guermazi
Journal:  Osteoarthritis Cartilage       Date:  2015-08-28       Impact factor: 6.576

2.  Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study.

Authors:  Ali Guermazi; Frank W Roemer; Daichi Hayashi; Michel D Crema; Jingbo Niu; Yuqing Zhang; Monica D Marra; Avinash Katur; John A Lynch; George Y El-Khoury; Kristin Baker; Laura B Hughes; Michael C Nevitt; David T Felson
Journal:  Ann Rheum Dis       Date:  2010-12-27       Impact factor: 19.103

3.  The association between meniscal damage of the posterior horns and localized posterior synovitis detected on T1-weighted contrast-enhanced MRI--the MOST study.

Authors:  Frank W Roemer; David T Felson; Tianzhong Yang; Jingbo Niu; Michel D Crema; Martin Englund; Michael C Nevitt; Yuqing Zhang; John A Lynch; George Y El Khoury; James Torner; Cora E Lewis; Ali Guermazi
Journal:  Semin Arthritis Rheum       Date:  2012-12-25       Impact factor: 5.532

4.  Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score).

Authors:  D J Hunter; A Guermazi; G H Lo; A J Grainger; P G Conaghan; R M Boudreau; F W Roemer
Journal:  Osteoarthritis Cartilage       Date:  2011-05-23       Impact factor: 6.576

5.  Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis.

Authors:  Svetlana Krasnokutsky; Ilana Belitskaya-Lévy; Jenny Bencardino; Jonathan Samuels; Mukundan Attur; Ravinder Regatte; Pamela Rosenthal; Jeffrey Greenberg; Mark Schweitzer; Steven B Abramson; Leon Rybak
Journal:  Arthritis Rheum       Date:  2011-10

6.  Peripatellar synovitis: comparison between non-contrast-enhanced and contrast-enhanced MRI and association with pain. The MOST study.

Authors:  M D Crema; D T Felson; F W Roemer; J Niu; M D Marra; Y Zhang; J A Lynch; G Y El-Khoury; C E Lewis; A Guermazi
Journal:  Osteoarthritis Cartilage       Date:  2012-12-28       Impact factor: 6.576

Review 7.  MRI-based semiquantitative scoring of joint pathology in osteoarthritis.

Authors:  Ali Guermazi; Frank W Roemer; Ida K Haugen; Michel D Crema; Daichi Hayashi
Journal:  Nat Rev Rheumatol       Date:  2013-01-15       Impact factor: 20.543

8.  Synovitis in knee osteoarthritis: a precursor of disease?

Authors:  I Atukorala; C K Kwoh; A Guermazi; F W Roemer; R M Boudreau; M J Hannon; D J Hunter
Journal:  Ann Rheum Dis       Date:  2014-12-08       Impact factor: 19.103

9.  Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis.

Authors:  Guangfeng Ruan; Jianhua Xu; Kang Wang; Shuang Zheng; Juan Wu; Fuqin Bian; Bingru Chang; Yan Zhang; Tao Meng; Zhaohua Zhu; Weiyu Han; Changhai Ding
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

10.  A comparison of dedicated 1.0 T extremity MRI vs large-bore 1.5 T MRI for semiquantitative whole organ assessment of osteoarthritis: the MOST study.

Authors:  F W Roemer; J A Lynch; J Niu; Y Zhang; M D Crema; I Tolstykh; G Y El-Khoury; D T Felson; C E Lewis; M C Nevitt; A Guermazi
Journal:  Osteoarthritis Cartilage       Date:  2009-09-09       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.